• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT CRM S.R.L. ENO; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT CRM S.R.L. ENO; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT) Back to Search Results
Model Number ENO DR
Device Problems Pacing Inadequately (1442); Device Sensing Problem (2917)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/22/2021
Event Type  malfunction  
Manufacturer Narrative
The device involved in this mdr report is not approved in the united states; however, it is similar to a device manufactured by microport crm that was cleared or approved by fda for marketing in the united states.
 
Event Description
Reportedly, the patient is pacemaker dependent with a sinus rhythm at 70 bpm.The leads were implanted with good measurements (5mv for the atrial detection).The leads were connected to the subject pacemaker; pacing was observed in both chambers.After the intervention, the pacemaker was interrogated which terminated the automatic implantation detection.Atrial sensing test revealed p-wave amplitude values at 3.06mv; however, the pacemaker was still pacing in the atrial channel.The pacing mode was reprogrammed to vdd and the pacemaker followed then the spontaneous atrial rhythm.The device was reprogrammed to ddd mode and normal pacing following p-wave could be observed.
 
Manufacturer Narrative
D3 and g1 updated.Please refer to the attached analysis report.
 
Event Description
Reportedly, the patient is pacemaker dependent with a sinus rhythm at 70 bpm.The leads were implanted with good measurements (5mv for the atrial detection).The leads were connected to the subject pacemaker; pacing was observed in both chambers.After the intervention, the pacemaker was interrogated which terminated the automatic implantation detection.Atrial sensing test revealed p-wave amplitude values at 3.06mv; however, the pacemaker was still pacing in the atrial channel.The pacing mode was reprogrammed to vdd and the pacemaker followed then the spontaneous atrial rhythm.The device was reprogrammed to ddd mode and normal pacing following p-wave could be observed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENO
Type of Device
IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)
Manufacturer (Section D)
MICROPORT CRM S.R.L.
via crescentino s.n.
saluggia (vc), 13040
IT  13040
MDR Report Key11483091
MDR Text Key239775739
Report Number1000165971-2021-00346
Device Sequence Number1
Product Code LWP
UDI-Device Identifier08031527017181
UDI-Public(01)08031527017181(11)201006(17)221006
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 08/31/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/06/2022
Device Model NumberENO DR
Device Catalogue NumberENO DR
Device Lot NumberS0467
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date02/19/2021
Initial Date Manufacturer Received 02/19/2021
Initial Date FDA Received03/15/2021
Supplement Dates Manufacturer Received08/02/2021
Supplement Dates FDA Received08/31/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-